Normal view MARC view ISBD view

JAK2 inhibitors in the treatment of myeloproliferative neoplasms.

Tibes, Raoul

JAK2 inhibitors in the treatment of myeloproliferative neoplasms. [electronic resource] - Expert opinion on investigational drugs Dec 2012 - 1755-74 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-7658

Standard No.: 10.1517/13543784.2012.721352 doi

Subjects--Topical Terms:
Animals
Antineoplastic Agents--therapeutic use
Bone Marrow Neoplasms--drug therapy
Humans
Janus Kinase 2--antagonists & inhibitors
Mutation
Protein Kinase Inhibitors--therapeutic use
STAT Transcription Factors--antagonists & inhibitors
Signal Transduction

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)